Researchers at Oulu University Hospital found that the ChestLink software identified normal studies with 99.8% sensitivity and specificity of 36.4%, with a "minimal" number of false negatives and no critical findings missed. The application analyzed 10,000 chest x-rays of Finnish primary healthcare patients.

Researchers wrote that using AI to rule out normal studies could optimize the use of resources in healthcare, such as radiology workforces.